<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00708331</url>
  </required_header>
  <id_info>
    <org_study_id>EyeKon SC25-FOLD</org_study_id>
    <nct_id>NCT00708331</nct_id>
  </id_info>
  <brief_title>Hydrophilic Acrylic Intraocular Lens</brief_title>
  <official_title>SC25-FOLD Hydrophilic Acrylic Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeKon Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EyeKon Medical, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of Hydrophilic Acrylic&#xD;
      Intraocular Lens after cataract surgery&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>August 2002</start_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>At all pre/post op CRFs for 2 yrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>2yrs</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Cataract Extraction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2 HEMA Hydrophilic Acrylic Intraocular Lens</intervention_name>
    <description>2 HEMA Hydrophilic Acrylic Intraocular Lens implanted into the posterior capsule following cataract surgery for patient life duration.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is in good general and ocular health, having a vision-reducing cataract in&#xD;
             the intended operative eye&#xD;
&#xD;
          -  The patient is willing and able to complete all required postoperative visits.&#xD;
&#xD;
          -  The patient is willing to sign a statement of informed consent.&#xD;
&#xD;
        Preoperative Exclusion Criteria:&#xD;
&#xD;
          -  The patient is under the age of 18&#xD;
&#xD;
          -  The patient has had prior intraocular surgery in the operative eye.&#xD;
&#xD;
          -  The patient has systemic diseases with ocular manifestations (e.g. diabetes,&#xD;
             complications of immune deficiency syndrome), which may contribute to postoperative&#xD;
             confounding of data interpretation.&#xD;
&#xD;
          -  The patient's worst seeing eye is 20/70 or worse.&#xD;
&#xD;
          -  The patient has multiple surgical procedures at the time of implant.&#xD;
&#xD;
          -  The patient has chronic use of steroids, immunosuppressive and/or antineoplastic&#xD;
             agents.&#xD;
&#xD;
          -  The patient has acute infection, inflammation of the eye.&#xD;
&#xD;
          -  Iris atrophy&#xD;
&#xD;
          -  Proliferative diabetic retinopathy.&#xD;
&#xD;
          -  Chronic, medically uncontrolled glaucoma&#xD;
&#xD;
          -  Chronic uveitis, iritis, iridocyclitis or rubeosis of the lids&#xD;
&#xD;
          -  Rubella, traumatic or congenital/developmental cataract.&#xD;
&#xD;
          -  Severe retinal pathology (e.g. retinal tear, detachment, etc).&#xD;
&#xD;
        Operative Patient Exclusion Criteria&#xD;
&#xD;
          -  Capsular rupture&#xD;
&#xD;
          -  Vitreous loss&#xD;
&#xD;
          -  Hyphema&#xD;
&#xD;
          -  Zonular disinsertion&#xD;
&#xD;
          -  Surgical Complications- In the event of a complication during surgery, the surgeon&#xD;
             should decide whether the stability of the hydrophilic acrylic lens would be&#xD;
             compromised by the complication, e.g. in the event of zonular damage of major capsule&#xD;
             rupture. If the lens stability would be compromised, the hydrophilic acrylic lens&#xD;
             should not be implanted and the surgeon should make arrangements to implant an&#xD;
             alternative lens.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Garvey, M.D.</last_name>
    <role>Study Director</role>
  </overall_official>
  <overall_official>
    <last_name>David C Brown, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eye Centers of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael S Korenfeld, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Comprehensive Eye Care LTD</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James E Croley, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cataract and Refractive Institute of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Larry Perich, D.O.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Perch Eye Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas L Croley, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Florida Eye Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Farrell C Tyson, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cape Coral Eye Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James P Gills, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Lukes Cataract and Laser Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Weinstock, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Eye Institute of West Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cape Coral Eye Center</name>
      <address>
        <city>Cape Coral</city>
        <state>Florida</state>
        <zip>33904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cataract and Refractive Institute of Florida</name>
      <address>
        <city>Cape Coral</city>
        <state>Florida</state>
        <zip>33990</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Centers of Florida</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riverside Park Surgicenter</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Eye Institute of West Florida</name>
      <address>
        <city>Largo</city>
        <state>Florida</state>
        <zip>33770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Perich Eye Center</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Florida Eye Institute</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34474</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Lukes Cataract and Laser Center</name>
      <address>
        <city>Tarpon Springs</city>
        <state>Florida</state>
        <zip>34688</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Comprehensive Eye Care Ltd.</name>
      <address>
        <city>Washington</city>
        <state>Missouri</state>
        <zip>63090</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>June 30, 2008</study_first_submitted>
  <study_first_submitted_qc>June 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2008</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <name_title>Mark D. Robinson, President and CEO</name_title>
    <organization>EyeKon Medical, Inc.</organization>
  </responsible_party>
  <keyword>Cataract</keyword>
  <keyword>Extraction</keyword>
  <keyword>Intraocular Lens</keyword>
  <keyword>Hydrophilic Acrylic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

